Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis
S.J.L.B. Zweers(Amsterdam UMC Location University of Amsterdam), Frank G. Schaap(Maastricht University), Ulrich Beuers(Amsterdam University Medical Centers), Tom H. Karlsen(Oslo University Hospital), Mette Vesterhus(Deaconess Hospital), Mina Komuta(Cliniques Universitaires Saint-Luc), María J. Perugorria(Ikerbasque), D. Rudi de Waart(Amsterdam UMC Location University of Amsterdam), Tania Roskams(KU Leuven), Anje A. te Velde(University of Amsterdam), Shanna Tol(Amsterdam UMC Location University of Amsterdam), Jesús M. Bañales(University of the Basque Country), Johannes R. Hov(Oslo University Hospital), Jung‐Chin Chang(Amsterdam UMC Location University of Amsterdam), Wouter J. de Jonge(University of Bonn), Peter L. M. Jansen(Academic Medical Center), Alexey Shiryaev(UiT The Arctic University of Norway)
Cited by 47
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k